435 related articles for article (PubMed ID: 28151883)
1. Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.
Yu SF; Chen JF; Chen YC; Lai HM; Ko CH; Chiu WC; Su FM; Hsu CY; Su BY; Wu CH; Cheng TT
Medicine (Baltimore); 2017 Feb; 96(5):e5959. PubMed ID: 28151883
[TBL] [Abstract][Full Text] [Related]
2. The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS).
Chen JF; Yu SF; Hsu CY; Chiu WC; Wu CH; Lai HM; Chen YC; Su YJ; Chen JF; Cheng TT
Arch Osteoporos; 2019 Oct; 14(1):101. PubMed ID: 31650396
[TBL] [Abstract][Full Text] [Related]
3. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
4. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
[TBL] [Abstract][Full Text] [Related]
6. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
Wang Y; Yu S; Hsu C; Tsai C; Cheng T
Osteoporos Int; 2020 Mar; 31(3):475-483. PubMed ID: 31696272
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
[TBL] [Abstract][Full Text] [Related]
8. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
[TBL] [Abstract][Full Text] [Related]
9. The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study.
Majumdar SR; Lix LM; Morin SN; Yogendran M; Metge CJ; Leslie WD
J Rheumatol; 2013 Oct; 40(10):1736-41. PubMed ID: 23818715
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population.
Ratnasingam J; Niyaz M; Mariyappan S; Ong T; Chan SP; Hew FL; Yeap SS; Velaiutham S; Thambiah SC; Lekamwasam S
Arch Osteoporos; 2024 Mar; 19(1):18. PubMed ID: 38503995
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
[TBL] [Abstract][Full Text] [Related]
13. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
Bultink IE; Baden M; Lems WF
Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
[TBL] [Abstract][Full Text] [Related]
15. Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.
Tsai MS; Zhang JY; Sun HY; Liu WC; Wu PY; Yang CJ; Hung CC
J Int AIDS Soc; 2019 Aug; 22(8):e25383. PubMed ID: 31423752
[TBL] [Abstract][Full Text] [Related]
16. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
17. FRAX-derived intervention and assessment thresholds for osteoporosis in ten Middle Eastern countries.
Naseri A; Bakhshayeshkaram M; Salehi S; Heydari ST; Dabbaghmanesh MH; Dabbaghmanesh MM
Arch Osteoporos; 2024 May; 19(1):41. PubMed ID: 38780743
[TBL] [Abstract][Full Text] [Related]
18. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
[TBL] [Abstract][Full Text] [Related]
20. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
